Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

NCT05921253 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Lymphoma

Interventions

DEVICE: PARASYM neuromodulation device
DEVICE: PARASYM neuromodulation device

Sponsor

University of Oklahoma